Literature DB >> 27031289

The role of obesity measures in the development and persistence of major depressive disorder.

Deborah Gibson-Smith1, Mariska Bot2, Nadine Pg Paans2, Marjolein Visser3, Ingeborg Brouwer4, Brenda Wjh Penninx2.   

Abstract

BACKGROUND: The role of obesity with the development of major depressive disorder (MDD) requires conformation and whether obesity contributes to more chronic depression in persons with established (MDD) is unknown. This study examined the longitudinal relationship of body mass index (BMI) and waist circumference with the incidence and persistence of MDD over 2-year and 6-year periods.
METHOD: Data were sourced from the Netherlands Study of Depression and Anxiety. MDD was established with Composite International Diagnostic Interviews. The relationship of BMI and waist circumference with the development of depression two and six years later were estimated in the subsample with no current psychopathology at baseline. Associations with the persistence of depression was estimated in the subsample with current MDD.
RESULTS: Higher BMI at baseline, but not waist circumference, slightly increased the odds of the development of MDD after two years (odds ratio (OR) per standard deviation increase: 1.11; p=0.03), This relationship was not significant after adjustment for health and lifestyle variables. Conversely, over a 6-year period both BMI and waist circumference moderately increased the odds of developing MDD even after adjustment (OR:1.17; p=0.05, OR:1.20; p=0.05). Persistence of MDD in currently depressed subjects, is not related with BMI or waist circumference (adjusted OR:0.93; p=0.2, OR:0.91; p=0.15). LIMITATIONS: Development of depression may differ in participants lost to follow-up.
CONCLUSION: Over a 6 year period, patients with higher BMI show a slightly increased risk of development of depression. However, in depressed patients there is no relationship between BMI and the persistence of depression.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27031289     DOI: 10.1016/j.jad.2016.03.032

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Association of poorer dietary quality and higher dietary inflammation with greater symptom severity in depressed individuals with appetite loss.

Authors:  Kaiping Burrows; Jennifer L Stewart; Chase Antonacci; Rayus Kuplicki; Katie Thompson; Ashlee Taylor; T Kent Teague; Martin P Paulus
Journal:  J Affect Disord       Date:  2019-12-02       Impact factor: 4.839

Review 2.  Sex Differences in Obesity and Mental Health.

Authors:  Jena Shaw Tronieri; Courtney McCuen Wurst; Rebecca L Pearl; Kelly C Allison
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

3.  The effect of obesity on treatment outcomes for low back pain.

Authors:  Stanley C Ewald; Eric L Hurwitz; Anupama Kizhakkeveettil
Journal:  Chiropr Man Therap       Date:  2016-12-12

4.  Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder.

Authors:  Marlene P Freeman; Rebecca S Hock; George I Papakostas; Heidi Judge; Cristina Cusin; Sanjay J Mathew; Gerard Sanacora; Dan V Iosifescu; Charles DeBattista; Madhukar H Trivedi; Maurizio Fava
Journal:  J Clin Psychopharmacol       Date:  2020 May/Jun       Impact factor: 3.118

5.  Development of the Weight-Related Sign and Symptom Measure.

Authors:  Meryl Brod; Lise Højbjerre; Kathryn M Pfeiffer; Robyn Sayner; Henrik H Meincke; Donald L Patrick
Journal:  J Patient Rep Outcomes       Date:  2018-04-02

6.  Regulatory T Cells As Supporters of Psychoimmune Resilience: Toward Immunotherapy of Major Depressive Disorder.

Authors:  Pierre Ellul; Encarnita Mariotti-Ferrandiz; Marion Leboyer; David Klatzmann
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.